CHRONIC MYELOID LEUKEMIA (CML)
Clinical trials for CHRONIC MYELOID LEUKEMIA (CML) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOID LEUKEMIA (CML) trials appear
Sign up with your email to follow new studies for CHRONIC MYELOID LEUKEMIA (CML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered donor cells aim to beat blood cancer without severe side effects
Disease control OngoingThis study tests a new way to treat children and young adults with high-risk blood cancers like leukemia and lymphoma. Doctors take blood cells from a family donor, remove certain T cells that can cause a harmful immune reaction, and then transplant the modified cells. The goal i…
Matched conditions: CHRONIC MYELOID LEUKEMIA (CML)
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Could a malaria drug boost leukemia treatment?
Disease control OngoingThis Phase 2 trial in Nigeria tests whether adding artesunate, a malaria drug, to the standard CML medication imatinib can improve treatment outcomes. 75 adults with chronic myeloid leukemia will receive either imatinib alone or imatinib plus artesunate. The goal is to see if the…
Matched conditions: CHRONIC MYELOID LEUKEMIA (CML)
Phase: PHASE2 • Sponsor: Obafemi Awolowo University • Aim: Disease control
Last updated Jun 26, 2026 14:03 UTC